Avalo Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US05338F3064
USD
14.37
-1.59 (-9.96%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAvalo Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
-9.96%
-0.84%
1W
-4.01%
-0.87%
1M
-15.57%
0.87%
YTD
-20.87%
1.06%
1Y
77.19%
15.4%
3Y
269.41%
67.24%
5Y
-99.85%
80.61%
10Y
-99.85%
261.71%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.69%
0%
-10.69%
6 Months
60.2%
0%
60.2%
1 Year
77.19%
0%
77.19%
2 Years
223.65%
0%
223.65%
3 Years
269.41%
0%
269.41%
4 Years
-99.44%
0%
-99.44%
5 Years
-99.85%
0%
-99.85%

Avalo Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary